Healthier Communities

CSL is committed to advancing equitable access to its medicines and vaccines by designing access and affordability programs to serve vulnerable populations and expand strategic donations.

• Through extension of CSL's existing World Federation of Haemophilia (WFH) partnership, by FY2030, CSL aims to donate products that enable 2,100 people with bleeding disorders to access prophylaxis therapy across 25 low- and middle-income countries.

• In support of reaching more communities and patients, through discounted products, CSL has announced a new aspirational commitment to treat up to 450,000 people with anaemia in at least three low- and middle-income countries with CSL Vifor's Ferinject^® by FY2030

CSL's ambition is to create best-in-class donor experience in partnership with donors and communities, by continuously innovating the donation process, supporting donors' holistic well-being, and investing in the health equity of donor communities.

• CSL's commitment for FY2030 is to initiate new programs to promote health awareness resources, ensuring that at least 30% of donors obtain access.

• Furthermore, CSL intends to increase donor satisfaction survey results, utilising a new customer satisfaction methodology to be implemented and baselined in FY25.

CSL's commitment is to elevate the Patient Experience in drug development by embedding patient insights and lived experience through patient-informed clinical development programs and formalising plans to include representative populations.

CSL's commitment for FY2030:

• Informed Product Development: all of CSL's therapeutic product development programs are informed by patient insights.

• Representative Clinical Trials: Phase III clinical trials incorporate participants that are representative of the target indicated population.

CSLs seeks to attract, develop, and retain top talent with diverse identities, cultures, backgrounds, skills, and lived experiences through robust talent pipelines, personalised development journeys, and an embedded culture of inclusion where all backgrounds and perspectives belong, develop, and thrive.

Learn more on our Careers page, and about our inclusion and belonging progress in FY26 and goals for FY27 in our Corporate Governance Statement.

CSL extends its commitment to sustainability beyond its four walls and across its value chain, by extending its inclusion and belonging values to tier 1 suppliers, setting higher supplier diversity targets and providing support for diverse suppliers.